Jeffrey C. Pepe - Interim CEO and GC at ARS Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CEO and GC
Stock Symbol
SPRY on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jeffrey C. Pepe since 9/17/2023

Holdings reported by Jeffrey C. Pepe for ARS Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 52.3K $198K $3.78 Sep 2, 2022 Direct

There are no transactions reported by Jeffrey C. Pepe for ARS Pharmaceuticals, Inc.